‘Gliadel’ recommended as adjunct in recurrent glioblastoma

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1996

Schlagwörter:	Malignant Glioma Glioblastoma Multiforme Antineoplastic Drug Carmustine Recurrent Glioblastoma

Anmerkung:	© Adis International Ltd 1996

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1043(1996), 1 vom: Juni, Seite 22-22
Übergeordnetes Werk:	volume:1043 ; year:1996 ; number:1 ; month:06 ; pages:22-22

Links:	Volltext

DOI / URN:	10.2165/00128413-199610430-00049

Katalog-ID:	SPR036200824

Internformat


LEADER	01000caa a22002652 4500
001	SPR036200824
003	DE-627
005	20230519185357.0
007	cr uuu---uuuuu
008	201007s1996 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-199610430-00049 \|2 doi
035			\|a (DE-627)SPR036200824
035			\|a (SPR)00128413-199610430-00049-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a ‘Gliadel’ recommended as adjunct in recurrent glioblastoma
264		1	\|c 1996
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1996
650		4	\|a Malignant Glioma \|7 (dpeaa)DE-He213
650		4	\|a Glioblastoma Multiforme \|7 (dpeaa)DE-He213
650		4	\|a Antineoplastic Drug \|7 (dpeaa)DE-He213
650		4	\|a Carmustine \|7 (dpeaa)DE-He213
650		4	\|a Recurrent Glioblastoma \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1043(1996), 1 vom: Juni, Seite 22-22 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1043 \|g year:1996 \|g number:1 \|g month:06 \|g pages:22-22
856	4	0	\|u https://dx.doi.org/10.2165/00128413-199610430-00049 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1043 \|j 1996 \|e 1 \|c 06 \|h 22-22

Indexfelder

matchkey_str	article:22306056:1996----::laercmeddsducircre
hierarchy_sort_str	1996
publishDate	1996
allfields	10.2165/00128413-199610430-00049 doi (DE-627)SPR036200824 (SPR)00128413-199610430-00049-e DE-627 ger DE-627 rakwb eng ‘Gliadel’ recommended as adjunct in recurrent glioblastoma 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Malignant Glioma (dpeaa)DE-He213 Glioblastoma Multiforme (dpeaa)DE-He213 Antineoplastic Drug (dpeaa)DE-He213 Carmustine (dpeaa)DE-He213 Recurrent Glioblastoma (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1043(1996), 1 vom: Juni, Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1043 year:1996 number:1 month:06 pages:22-22 https://dx.doi.org/10.2165/00128413-199610430-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1043 1996 1 06 22-22
spelling	10.2165/00128413-199610430-00049 doi (DE-627)SPR036200824 (SPR)00128413-199610430-00049-e DE-627 ger DE-627 rakwb eng ‘Gliadel’ recommended as adjunct in recurrent glioblastoma 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Malignant Glioma (dpeaa)DE-He213 Glioblastoma Multiforme (dpeaa)DE-He213 Antineoplastic Drug (dpeaa)DE-He213 Carmustine (dpeaa)DE-He213 Recurrent Glioblastoma (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1043(1996), 1 vom: Juni, Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1043 year:1996 number:1 month:06 pages:22-22 https://dx.doi.org/10.2165/00128413-199610430-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1043 1996 1 06 22-22
allfields_unstemmed	10.2165/00128413-199610430-00049 doi (DE-627)SPR036200824 (SPR)00128413-199610430-00049-e DE-627 ger DE-627 rakwb eng ‘Gliadel’ recommended as adjunct in recurrent glioblastoma 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Malignant Glioma (dpeaa)DE-He213 Glioblastoma Multiforme (dpeaa)DE-He213 Antineoplastic Drug (dpeaa)DE-He213 Carmustine (dpeaa)DE-He213 Recurrent Glioblastoma (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1043(1996), 1 vom: Juni, Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1043 year:1996 number:1 month:06 pages:22-22 https://dx.doi.org/10.2165/00128413-199610430-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1043 1996 1 06 22-22
allfieldsGer	10.2165/00128413-199610430-00049 doi (DE-627)SPR036200824 (SPR)00128413-199610430-00049-e DE-627 ger DE-627 rakwb eng ‘Gliadel’ recommended as adjunct in recurrent glioblastoma 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Malignant Glioma (dpeaa)DE-He213 Glioblastoma Multiforme (dpeaa)DE-He213 Antineoplastic Drug (dpeaa)DE-He213 Carmustine (dpeaa)DE-He213 Recurrent Glioblastoma (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1043(1996), 1 vom: Juni, Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1043 year:1996 number:1 month:06 pages:22-22 https://dx.doi.org/10.2165/00128413-199610430-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1043 1996 1 06 22-22
allfieldsSound	10.2165/00128413-199610430-00049 doi (DE-627)SPR036200824 (SPR)00128413-199610430-00049-e DE-627 ger DE-627 rakwb eng ‘Gliadel’ recommended as adjunct in recurrent glioblastoma 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Malignant Glioma (dpeaa)DE-He213 Glioblastoma Multiforme (dpeaa)DE-He213 Antineoplastic Drug (dpeaa)DE-He213 Carmustine (dpeaa)DE-He213 Recurrent Glioblastoma (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1043(1996), 1 vom: Juni, Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1043 year:1996 number:1 month:06 pages:22-22 https://dx.doi.org/10.2165/00128413-199610430-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1043 1996 1 06 22-22
language	English
source	Enthalten in Inpharma weekly 1043(1996), 1 vom: Juni, Seite 22-22 volume:1043 year:1996 number:1 month:06 pages:22-22
sourceStr	Enthalten in Inpharma weekly 1043(1996), 1 vom: Juni, Seite 22-22 volume:1043 year:1996 number:1 month:06 pages:22-22
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Malignant Glioma Glioblastoma Multiforme Antineoplastic Drug Carmustine Recurrent Glioblastoma
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1996-06-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036200824
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036200824</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519185357.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1996 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199610430-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036200824</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199610430-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">‘Gliadel’ recommended as adjunct in recurrent glioblastoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1996</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malignant Glioma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glioblastoma Multiforme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Drug</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carmustine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recurrent Glioblastoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1043(1996), 1 vom: Juni, Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1043</subfield><subfield code="g">year:1996</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199610430-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1043</subfield><subfield code="j">1996</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	‘Gliadel’ recommended as adjunct in recurrent glioblastoma Malignant Glioma (dpeaa)DE-He213 Glioblastoma Multiforme (dpeaa)DE-He213 Antineoplastic Drug (dpeaa)DE-He213 Carmustine (dpeaa)DE-He213 Recurrent Glioblastoma (dpeaa)DE-He213
topic	misc Malignant Glioma misc Glioblastoma Multiforme misc Antineoplastic Drug misc Carmustine misc Recurrent Glioblastoma
spellingShingle	misc Malignant Glioma misc Glioblastoma Multiforme misc Antineoplastic Drug misc Carmustine misc Recurrent Glioblastoma ‘Gliadel’ recommended as adjunct in recurrent glioblastoma
topic_unstemmed	misc Malignant Glioma misc Glioblastoma Multiforme misc Antineoplastic Drug misc Carmustine misc Recurrent Glioblastoma
topic_browse	misc Malignant Glioma misc Glioblastoma Multiforme misc Antineoplastic Drug misc Carmustine misc Recurrent Glioblastoma
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	‘Gliadel’ recommended as adjunct in recurrent glioblastoma
ctrlnum	(DE-627)SPR036200824 (SPR)00128413-199610430-00049-e
title_full	‘Gliadel’ recommended as adjunct in recurrent glioblastoma
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1996
contenttype_str_mv	txt
container_start_page	22
container_volume	1043
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-199610430-00049
title_sort	‘gliadel’ recommended as adjunct in recurrent glioblastoma
title_auth	‘Gliadel’ recommended as adjunct in recurrent glioblastoma
abstract	© Adis International Ltd 1996
abstractGer	© Adis International Ltd 1996
abstract_unstemmed	© Adis International Ltd 1996
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	‘Gliadel’ recommended as adjunct in recurrent glioblastoma
url	https://dx.doi.org/10.2165/00128413-199610430-00049
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-199610430-00049
up_date	2024-07-03T16:45:09.563Z
_version_	1803577049285132288
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036200824</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519185357.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1996 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199610430-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036200824</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199610430-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">‘Gliadel’ recommended as adjunct in recurrent glioblastoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1996</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malignant Glioma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glioblastoma Multiforme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Drug</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carmustine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recurrent Glioblastoma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1043(1996), 1 vom: Juni, Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1043</subfield><subfield code="g">year:1996</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199610430-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1043</subfield><subfield code="j">1996</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
score	7.399988

Nicht das Richtige dabei?

Schreiben Sie uns!

‘Gliadel’ recommended as adjunct in recurrent glioblastoma

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?